abstract |
The present invention relates to compounds of formula (IA) and formula (IB), and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and methods of using these compounds for the treatment of TGR5 mediated diseases or conditions : Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and m are as defined herein. |